Copyright Reports & Markets. All rights reserved.

Global Buprenorphine Hydrochloride Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Buprenorphine Hydrochloride Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Tablets
    • 1.3.3 Injection
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Buprenorphine Hydrochloride Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Analgesic
    • 1.4.3 Opioid Antagonist
  • 1.5 Global Buprenorphine Hydrochloride Market Size & Forecast
    • 1.5.1 Global Buprenorphine Hydrochloride Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Buprenorphine Hydrochloride Sales Quantity (2020-2031)
    • 1.5.3 Global Buprenorphine Hydrochloride Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Siegfried
    • 2.1.1 Siegfried Details
    • 2.1.2 Siegfried Major Business
    • 2.1.3 Siegfried Buprenorphine Hydrochloride Product and Services
    • 2.1.4 Siegfried Buprenorphine Hydrochloride Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Siegfried Recent Developments/Updates
  • 2.2 Sanofi
    • 2.2.1 Sanofi Details
    • 2.2.2 Sanofi Major Business
    • 2.2.3 Sanofi Buprenorphine Hydrochloride Product and Services
    • 2.2.4 Sanofi Buprenorphine Hydrochloride Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Sanofi Recent Developments/Updates
  • 2.3 Johnson Matthey
    • 2.3.1 Johnson Matthey Details
    • 2.3.2 Johnson Matthey Major Business
    • 2.3.3 Johnson Matthey Buprenorphine Hydrochloride Product and Services
    • 2.3.4 Johnson Matthey Buprenorphine Hydrochloride Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Johnson Matthey Recent Developments/Updates
  • 2.4 Mallinckrodt
    • 2.4.1 Mallinckrodt Details
    • 2.4.2 Mallinckrodt Major Business
    • 2.4.3 Mallinckrodt Buprenorphine Hydrochloride Product and Services
    • 2.4.4 Mallinckrodt Buprenorphine Hydrochloride Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Mallinckrodt Recent Developments/Updates
  • 2.5 Noramco
    • 2.5.1 Noramco Details
    • 2.5.2 Noramco Major Business
    • 2.5.3 Noramco Buprenorphine Hydrochloride Product and Services
    • 2.5.4 Noramco Buprenorphine Hydrochloride Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Noramco Recent Developments/Updates
  • 2.6 Unichemlabs
    • 2.6.1 Unichemlabs Details
    • 2.6.2 Unichemlabs Major Business
    • 2.6.3 Unichemlabs Buprenorphine Hydrochloride Product and Services
    • 2.6.4 Unichemlabs Buprenorphine Hydrochloride Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Unichemlabs Recent Developments/Updates
  • 2.7 Arevipharma
    • 2.7.1 Arevipharma Details
    • 2.7.2 Arevipharma Major Business
    • 2.7.3 Arevipharma Buprenorphine Hydrochloride Product and Services
    • 2.7.4 Arevipharma Buprenorphine Hydrochloride Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Arevipharma Recent Developments/Updates
  • 2.8 Resonance-labs
    • 2.8.1 Resonance-labs Details
    • 2.8.2 Resonance-labs Major Business
    • 2.8.3 Resonance-labs Buprenorphine Hydrochloride Product and Services
    • 2.8.4 Resonance-labs Buprenorphine Hydrochloride Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Resonance-labs Recent Developments/Updates
  • 2.9 Sun Pharma
    • 2.9.1 Sun Pharma Details
    • 2.9.2 Sun Pharma Major Business
    • 2.9.3 Sun Pharma Buprenorphine Hydrochloride Product and Services
    • 2.9.4 Sun Pharma Buprenorphine Hydrochloride Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Sun Pharma Recent Developments/Updates
  • 2.10 Rusan Pharma
    • 2.10.1 Rusan Pharma Details
    • 2.10.2 Rusan Pharma Major Business
    • 2.10.3 Rusan Pharma Buprenorphine Hydrochloride Product and Services
    • 2.10.4 Rusan Pharma Buprenorphine Hydrochloride Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 Rusan Pharma Recent Developments/Updates
  • 2.11 Micro Orgo Chem
    • 2.11.1 Micro Orgo Chem Details
    • 2.11.2 Micro Orgo Chem Major Business
    • 2.11.3 Micro Orgo Chem Buprenorphine Hydrochloride Product and Services
    • 2.11.4 Micro Orgo Chem Buprenorphine Hydrochloride Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 Micro Orgo Chem Recent Developments/Updates
  • 2.12 Faranshimi
    • 2.12.1 Faranshimi Details
    • 2.12.2 Faranshimi Major Business
    • 2.12.3 Faranshimi Buprenorphine Hydrochloride Product and Services
    • 2.12.4 Faranshimi Buprenorphine Hydrochloride Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 Faranshimi Recent Developments/Updates

3 Competitive Environment: Buprenorphine Hydrochloride by Manufacturer

  • 3.1 Global Buprenorphine Hydrochloride Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Buprenorphine Hydrochloride Revenue by Manufacturer (2020-2025)
  • 3.3 Global Buprenorphine Hydrochloride Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Buprenorphine Hydrochloride by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Buprenorphine Hydrochloride Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Buprenorphine Hydrochloride Manufacturer Market Share in 2024
  • 3.5 Buprenorphine Hydrochloride Market: Overall Company Footprint Analysis
    • 3.5.1 Buprenorphine Hydrochloride Market: Region Footprint
    • 3.5.2 Buprenorphine Hydrochloride Market: Company Product Type Footprint
    • 3.5.3 Buprenorphine Hydrochloride Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Buprenorphine Hydrochloride Market Size by Region
    • 4.1.1 Global Buprenorphine Hydrochloride Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Buprenorphine Hydrochloride Consumption Value by Region (2020-2031)
    • 4.1.3 Global Buprenorphine Hydrochloride Average Price by Region (2020-2031)
  • 4.2 North America Buprenorphine Hydrochloride Consumption Value (2020-2031)
  • 4.3 Europe Buprenorphine Hydrochloride Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Buprenorphine Hydrochloride Consumption Value (2020-2031)
  • 4.5 South America Buprenorphine Hydrochloride Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Buprenorphine Hydrochloride Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Buprenorphine Hydrochloride Sales Quantity by Type (2020-2031)
  • 5.2 Global Buprenorphine Hydrochloride Consumption Value by Type (2020-2031)
  • 5.3 Global Buprenorphine Hydrochloride Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Buprenorphine Hydrochloride Sales Quantity by Application (2020-2031)
  • 6.2 Global Buprenorphine Hydrochloride Consumption Value by Application (2020-2031)
  • 6.3 Global Buprenorphine Hydrochloride Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Buprenorphine Hydrochloride Sales Quantity by Type (2020-2031)
  • 7.2 North America Buprenorphine Hydrochloride Sales Quantity by Application (2020-2031)
  • 7.3 North America Buprenorphine Hydrochloride Market Size by Country
    • 7.3.1 North America Buprenorphine Hydrochloride Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Buprenorphine Hydrochloride Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Buprenorphine Hydrochloride Sales Quantity by Type (2020-2031)
  • 8.2 Europe Buprenorphine Hydrochloride Sales Quantity by Application (2020-2031)
  • 8.3 Europe Buprenorphine Hydrochloride Market Size by Country
    • 8.3.1 Europe Buprenorphine Hydrochloride Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Buprenorphine Hydrochloride Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Buprenorphine Hydrochloride Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Buprenorphine Hydrochloride Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Buprenorphine Hydrochloride Market Size by Region
    • 9.3.1 Asia-Pacific Buprenorphine Hydrochloride Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Buprenorphine Hydrochloride Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Buprenorphine Hydrochloride Sales Quantity by Type (2020-2031)
  • 10.2 South America Buprenorphine Hydrochloride Sales Quantity by Application (2020-2031)
  • 10.3 South America Buprenorphine Hydrochloride Market Size by Country
    • 10.3.1 South America Buprenorphine Hydrochloride Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Buprenorphine Hydrochloride Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Buprenorphine Hydrochloride Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Buprenorphine Hydrochloride Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Buprenorphine Hydrochloride Market Size by Country
    • 11.3.1 Middle East & Africa Buprenorphine Hydrochloride Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Buprenorphine Hydrochloride Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Buprenorphine Hydrochloride Market Drivers
  • 12.2 Buprenorphine Hydrochloride Market Restraints
  • 12.3 Buprenorphine Hydrochloride Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Buprenorphine Hydrochloride and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Buprenorphine Hydrochloride
  • 13.3 Buprenorphine Hydrochloride Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Buprenorphine Hydrochloride Typical Distributors
  • 14.3 Buprenorphine Hydrochloride Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Buprenorphine Hydrochloride market size was valued at US$ 148 million in 2024 and is forecast to a readjusted size of USD 168 million by 2031 with a CAGR of 1.9% during review period.
    Buprenorphine hydrochloride, a white crystalline powder, is a semisynthetic opioid analgesic used for the relief of moderate to severe pain. It is in the same chemical family of morphine, codeine and heroin. However, buprenorphine hydrochloride has the distinction of producing less euphoric effects than those drugs.
    Europe is the largest market with about 31% market share. Middle East& Africa and Asia-Pacific are follower.
    The main manufacturers are Siegfried, Sanofi, Johnson Matthey, Mallinckrodt, Noramco, Unichemlabs, Arevipharma, Resonance-labs, Sun Pharma, Rusan Pharma, Micro Orgo Chem, Faranshimi etc. Siegfried is the largest manufacturer with about 23% market share.
    This report is a detailed and comprehensive analysis for global Buprenorphine Hydrochloride market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Buprenorphine Hydrochloride market size and forecasts, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/g), 2020-2031
    Global Buprenorphine Hydrochloride market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/g), 2020-2031
    Global Buprenorphine Hydrochloride market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/g), 2020-2031
    Global Buprenorphine Hydrochloride market shares of main players, shipments in revenue ($ Million), sales quantity (Kg), and ASP (US$/g), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Buprenorphine Hydrochloride
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Buprenorphine Hydrochloride market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Siegfried, Sanofi, Johnson Matthey, Mallinckrodt, Noramco, Unichemlabs, Arevipharma, Resonance-labs, Sun Pharma, Rusan Pharma, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Buprenorphine Hydrochloride market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Tablets
    Injection
    Market segment by Application
    Analgesic
    Opioid Antagonist
    Major players covered
    Siegfried
    Sanofi
    Johnson Matthey
    Mallinckrodt
    Noramco
    Unichemlabs
    Arevipharma
    Resonance-labs
    Sun Pharma
    Rusan Pharma
    Micro Orgo Chem
    Faranshimi
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Buprenorphine Hydrochloride product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Buprenorphine Hydrochloride, with price, sales quantity, revenue, and global market share of Buprenorphine Hydrochloride from 2020 to 2025.
    Chapter 3, the Buprenorphine Hydrochloride competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Buprenorphine Hydrochloride breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Buprenorphine Hydrochloride market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Buprenorphine Hydrochloride.
    Chapter 14 and 15, to describe Buprenorphine Hydrochloride sales channel, distributors, customers, research findings and conclusion.

    Buy now